Searched for
A VAIDHEESH
Ophthalmic devices maker Appasamy appoints Annaswamy Vaidheesh as non-executive chairmanAppasamy Associates has appointed Annaswamy Vaidheesh as its non-executive chairman. With over 35 years of experience in the healthcare and...- Suven Pharmaceuticals names Vivek Sharma as executive chairmanSuven Pharma, backed by Advent International, has appointed Vivek Sharma as the new executive chairman effective September 20. Sharma bring...
- Suven, with Cohance and more, wants to become a CDMO powerhouse: Annaswamy Vaidheesh, executive chairman"We want to be a diversified, end-to-end capability outsourcing partner, serving customers from development to commercial scale. Doing this...
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline PharmaceuticalsIt is a mixed bag but API is definitely a very big element in the pharma industry which is emerging as one of the big component for growth ...
- Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...
- GlaxoSmithKline Pharma Q3 profit up 26% at Rs 113 croreRevenue from operations of the company stood at Rs 825.35 crore for the quarter.
- Focus on 20 key brands to drive growth: GlaxoSmithKline pharmaceuticalsAs part of its growth plans the company is also planning to aggressively expand its field force.
- More than 90% of revenues still come from acute therapy business: A Vaidheesh, GSK Pharma“The parent company feels confident that we are here to deliver.”
- We are investing 100 mn pounds in a manufacturing facility in Bangalore: Annaswamy Vaidheesh, GSK Pharma"It is global standards which we need to match up to. We are back in action with many of our brands like Neosporin which was not available ...
- There is a temporarily change in consumption habits: A Vaidheesh, GSK Pharma"Semi-wholesalers are not like big people they are the people like jobbers they picks up goods from one distributor who is selling GSK or a...
- Indian pharma sector going digital at a fast paceThe pharma industry’s marketing spends through digital platforms is estimated to shoot up nearly 50% in the next two years to touch Rs 220 ...
- Working towards 10-15% topline growth in next 5-6 years: A Vaidheesh, GSK Pharma"Considering the number of patients in India, we should be in a position to serve all of them. I do not think consideration should be on a ...
- GSK Pharma trying to find out what ammunition is needed to grow: MDThe Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.
- Pfizer and GlaxoSmithKline initiate leadership reshuffle in face of competition from domestic playersTop multinational drug makers Pfizer and GlaxoSmithKline have initiated major reshuffle of senior leadership teams in India in face of comp...
- GlaxoSmithKline appoints Annaswamy Vaidheesh as VP South AsiaVaidheesh’s last assignment was as Vice President, Corporate Government Affairs, Asia-Pacific with Johnson & Johnson based in Singapore.
- GSK appoints Annaswamy Vaidheesh as Vice President for South AsiaVaidheesh’s last assignment was as Vice President, Corporate Government Affairs, Asia-Pacific with Johnson & Johnson based in Singapore.
- Rs 18,000 crore required to extend health insurance coverageThe demographic dividend refers to a period when the share of young and working people outnumber dependents significantly.
- Lack of surgical seams push healthcare costsA surge in exports of sheep and goat guts for preparing sausages has brought domestic manufacturers of catgut sutures to the brink of closu...
- J&J to launch Mentor's aesthetic surgery products in IndiaThe US-based Johnson & Johnson (J&J) on Friday said it plans to launch products from the stable of Mentor Corp, the world's largest breast ...
Load More
